ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)

A disseminated gonococcal infection with spinal locations

Screening for osteoporosis in patients with inflammatory bowel diseases: a cross-sectional study

Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European Populations

Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis

Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease

The protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritis

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease

Value of lung ultrasonography for screening interstitial lung disease in patients with rheumatoid arthritis

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies

Increased risk of mortality in lung transplant patients with fragility fractures

Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study

Ankle retinacula abnormalities as features of psoriatic arthritis: An ultrasound study

Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study

Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis

Cardiac myxoma mimicking a spondyloarthritis flare

Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis

Hyperparathyroidism in a hemodialyzed patient

Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis

A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease

Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease

RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry

Anti-mutated citrullinated vimentin antibodies are increased in IPF patients

Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences

NKX2.1 mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study

Osteoporosis and risk of fracture in heart transplant patients

Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database

A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data

Impact of Sjögren's disease on quality of sexual life using the Qualisex score

Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

Characterisation of airway disease associated with Sjögren disease

Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study

Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials

[Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia]

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement

Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline

Rheumatoid arthritis-associated interstitial lung disease: A review

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review

Factors associated with anakinra effectiveness and risk of infection in crystal-related flares

Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease

Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE study

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial

Burden of comorbidities: Osteoporotic vertebral fracture during non-small cell lung cancer - the BONE study

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial

Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review